Improving visual outcomes in patients with Diabetic Macular Oedema undergoing Cataract Surgery: A prospective randomised clinical trial (the DiMECat Trial)

改善接受白内障手术的糖尿病黄斑水肿患者的视力结果：一项前瞻性随机临床试验（DiMECat 试验）

• 批准号: nhmrc : 1109330
• 负责人: A/Pr Lyndell Lim
• 金额: $ 12.8万
• 依托单位: Centre for Eye Research Australia Ltd
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-visual-outcomes-dimecat-trial/663080
• 关键词: Improving; visual; outcomes; patients; Diabetic

Cataract and diabetic retinopathy are the leading causes of visual loss in patients with diabetes, but unfortunately, cataract surgery in these patients often results in a loss of vision, rather than an improvement. The purpose of this study is to improve the visual outcomes in this group of patients, through the use of new, injected medicines that are given at the time of cataract surgery, thereby potentially changing current medical practice.

白内障和糖尿病视网膜病变是糖尿病患者视力丧失的主要原因，但不幸的是，这些患者的白内障手术通常会导致视力丧失，而不是改善。本研究的目的是通过使用白内障手术时给予的新型注射药物来改善这组患者的视力结果，从而有可能改变当前的医疗实践。